EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSCMIG00000008718
Gene Symbol: DHCR24
4 Cross references
209 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 13-Like

Ensembl ID : ENSCMIG00000001380
Gene Symbol: LOC103171904
3 Cross references
224 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSCMIG00000000216
Gene Symbol: HMGCR
3 Cross references
272 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1

Ensembl ID : ENSCMIG00000013158
Gene Symbol: PDPK1
4 Cross references
246 Possible Orthologues:

5'-Nucleotidase Ecto

Ensembl ID : ENSCMIG00000007573
Gene Symbol: NT5E
3 Cross references
249 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 1a B

Ensembl ID : ENSCMIG00000019109
Gene Symbol: HTR1AB
1 Cross references
149 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 2c, G Protein-Coupled-Like 1

Ensembl ID : ENSCMIG00000008016
Gene Symbol: HTR2CL1
1 Cross references
227 Possible Orthologues:

5-Hydroxytryptamine Receptor 1b

Ensembl ID : ENSCMIG00000004578
Gene Symbol: HTR1B
3 Cross references
244 Possible Orthologues:

5-Hydroxytryptamine Receptor 1e

Ensembl ID : ENSCMIG00000012414
Gene Symbol: HTR1E
4 Cross references
157 Possible Orthologues:

5-Hydroxytryptamine Receptor 2a

Ensembl ID : ENSCMIG00000012974
Gene Symbol: HTR2A
4 Cross references
217 Possible Orthologues:

5-Hydroxytryptamine Receptor 2b

Ensembl ID : ENSCMIG00000009676
Gene Symbol: HTR2B
4 Cross references
206 Possible Orthologues:

5-Hydroxytryptamine Receptor 3a

Ensembl ID : ENSCMIG00000001955
Gene Symbol: HTR3A
3 Cross references
207 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).